Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00073229 · ClinicalTrials.gov registry record
Immune Function of Infants With HIV
A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 80
- Enrollment target
NCT00073229: Completed study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
NCT00073229 is a clinical trial that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 80 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00073229 has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
Study Summary
This observational study will evaluate data from infants born to HIV infected mothers in order to better characterize disease progression in early HIV infection.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2000-07 |
| Est. Completion | 2005-06 |
What the finished NCT00073229 record still lists
NCT00073229 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00073229 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00073229 about?
NCT00073229 is a clinical study titled "Immune Function of Infants With HIV". This observational study will evaluate data from infants born to HIV infected mothers in order to better characterize disease progression in early HIV infection.
What is the current status of trial NCT00073229?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2000-07. Estimated completion is 2005-06.
Who is sponsoring clinical trial NCT00073229?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia